These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28288662)

  • 21. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
    Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
    J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
    Lassen KG; Ramyar KX; Bailey JR; Zhou Y; Siliciano RF
    PLoS Pathog; 2006 Jul; 2(7):e68. PubMed ID: 16839202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.
    Mousseau G; Clementz MA; Bakeman WN; Nagarsheth N; Cameron M; Shi J; Baran P; Fromentin R; Chomont N; Valente ST
    Cell Host Microbe; 2012 Jul; 12(1):97-108. PubMed ID: 22817991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
    Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cells.
    Green VA; Arbuthnot P; Weinberg MS
    Virol J; 2012 Nov; 9():272. PubMed ID: 23153325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.
    Ragheb JA; Couture L; Mullen C; Ridgway A; Morgan RA
    Hum Gene Ther; 1999 Jan; 10(1):103-12. PubMed ID: 10022535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.
    Malim MH; Freimuth WW; Liu J; Boyle TJ; Lyerly HK; Cullen BR; Nabel GJ
    J Exp Med; 1992 Oct; 176(4):1197-201. PubMed ID: 1402661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.
    Narayan V; Ravindra KC; Chiaro C; Cary D; Aggarwal BB; Henderson AJ; Prabhu KS
    J Mol Biol; 2011 Jul; 410(5):972-83. PubMed ID: 21763500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA.
    Mautino MR; Morgan RA
    Hum Gene Ther; 2002 Jun; 13(9):1027-37. PubMed ID: 12067436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
    Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
    Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.
    Raymond AD; Hasham M; Tsygankov AY; Henderson EE
    Virology; 2006 Sep; 352(2):253-67. PubMed ID: 16780912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages.
    Kang W; Marasco WA; Tong HI; Byron MM; Wu C; Shi Y; Sun S; Sun Y; Lu Y
    J Neuroinflammation; 2014 Nov; 11():195. PubMed ID: 25416164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
    Dave RS; Pomerantz RJ
    J Virol; 2004 Dec; 78(24):13687-96. PubMed ID: 15564478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication.
    San José E; Muñoz-Fernández MA; Alarcón B
    Hum Gene Ther; 1998 Jun; 9(9):1345-57. PubMed ID: 9650619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein.
    Siddappa NB; Venkatramanan M; Venkatesh P; Janki MV; Jayasuryan N; Desai A; Ravi V; Ranga U
    Retrovirology; 2006 Aug; 3():53. PubMed ID: 16916472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells.
    Lacombe B; Morel M; Margottin-Goguet F; Ramirez BC
    J Virol; 2016 Dec; 90(23):10972-10980. PubMed ID: 27681137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication.
    Bhargavan B; Woollard SM; Kanmogne GD
    Cell Signal; 2016 Feb; 28(2):7-22. PubMed ID: 26569339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy restricts HIV-1 infection by selectively degrading Tat in CD4+ T lymphocytes.
    Sagnier S; Daussy CF; Borel S; Robert-Hebmann V; Faure M; Blanchet FP; Beaumelle B; Biard-Piechaczyk M; Espert L
    J Virol; 2015 Jan; 89(1):615-25. PubMed ID: 25339774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.